AI-powered startup Abridge has raised $30M in a Series B investment round to continue developing its app for automatic medical note generation from doctor-patient conversations. The fundraise was led by Spark Capital and valued Abridge at $200M. The startup provides an alternative to dictation software, enabling physicians to spends less time on documentation, and has been adopted by Emory Healthcare, among others. The app integrates with electronic health records systems such as Epic, and will soon offer multilingual support. Future plans include patient-focused technologies and supporting non-doctor healthcare workers.

This Startup Raised $30 Million To Take On Microsoft's AI Notetaker For Doctors Forbes

Biden issued first-of-its-kind AI executive order; sets new safety assessments, civil rights, research on AI's labor market impact. Order outlines creating new safety, security standards, protecting consumer privacy, advancing equity, civil rights, protecting consumers, supporting workers, promoting innovation, competition, working with international partners. Order heralds globally strongest AI safety, security, trust actions.

Biden issues U.S.' first AI executive order, requiring safety assessments, civil rights guidance, research on labor market impact CNBC

Blackstone CEO Steve Schwarzman accuses remote workers of lesser productivity and cost savings. Vacancies in US office buildings due to rise in remote work post-pandemic. Many executives support full return to in-office work by 2026 despite hybrid-work model's equality benefits. Concerns over forcing women out of City with rollback of hybrid working.

Remote employees ‘don’t work as hard’, says head of world’s biggest commercial landlord The Guardian

ITC ruled Apple Watch violating Masimo patents, faced import ban. Upheld January ruling, Apple Watch infringed Masimo patent, possible exclusion period after 60 days. Contention, Masimo's light-based pulse oximetry. Apple accused of stealing Masimo's idea, poaching engineers. Apple argued, declined partnership as Masimo not consumer-focused. Apple could appeal, make modifications or settle with Masimo to avoid ban. Apple facing ongoing patent disputes with Masimo, AliveCor.

Apple Watch facing potential ban after losing Masimo patent case Ars Technica